The Efficacy of Surgical Site Treatment With Ropivacaine in Laparoscopic Surgery

NCT02826876 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-07-11

No results posted yet for this study

Summary

Using local analgesia in laparoscopic surgery in order to reduce pain and to reduce the use of narcotic drugs.

Conditions

Interventions

DRUG

Topical use

Topical use of Ropivacaine in laparoscopic surgery

OTHER

laparoscopic repair of inguinal hernia

intra-operative treatment with ropivacaine Vs placebo in laparoscopic repair of inguinal hernia

OTHER

laparoscopic bariatric surgery

intra-operative treatment with ropivacaine Vs placebo in laparoscopic bariatric surgery

Sponsors & Collaborators

  • Western Galilee Hospital-Nahariya

    lead OTHER_GOV

Principal Investigators

  • Moaad H Farraj, Dr · Galilee Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02826876 on ClinicalTrials.gov